• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Main Content

  • Billie Jean King supports Medtronic Diabetes awareness initiative

    Billie Jean King supports Medtronic Diabetes awareness initiative
  • Tandem stock rises after hours on Q3 beats, record sales

    Tandem stock rises after hours on Q3 beats, record sales
  • Insulet leadership talks patch pump competition, expanding type 2 diabetes market

    Insulet leadership talks patch pump competition, expanding type 2 diabetes market
  • Insulet increases guidance again on Q3 beats, 30% sales uptick

    Insulet increases guidance again on Q3 beats, 30% sales uptick
  • Senseonics posts Q3 sales beat, expects CE mark for Eversense 365 this year

    Senseonics posts Q3 sales beat, expects CE mark for Eversense 365 this year

Drug Tech

Dexcom Tidepool Oura Metabolic 1 (1)

Tidepool, Oura partner on data for diabetes research

Tidepool today announced a strategic collaboration with Oura to support a groundbreaking dataset for diabetes research. The initiative between the diabetes software developer and smart ring maker aims to create a comprehensive, multi-modal, … [Read More...] about Tidepool, Oura partner on data for diabetes research

Today on Drug Delivery Business

  • Billie Jean King supports Medtronic Diabetes awareness initiative
  • Tandem stock rises after hours on Q3 beats, record sales
  • Insulet leadership talks patch pump competition, expanding type 2 diabetes market
  • Insulet increases guidance again on Q3 beats, 30% sales uptick
  • Senseonics posts Q3 sales beat, expects CE mark for Eversense 365 this year
  • MIT engineers develop drug delivery patch for post-heart attack healing
  • Tandem achieves cybersecurity certification milestone

Sponsored Content

Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI

September 6, 2023 By Sponsored Content

Manufacturing automation is crucial to achieving the precision, quality, and volume required in the medical device industry. Advanced robotics, AI, modular designs, and wireless technology offer the … [Read More...] about Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI

More Sponsored Content >>

Featured Posts

Billie Jean King Medtronic MiniMed Blue Balloon Challenge

Billie Jean King supports Medtronic Diabetes awareness initiative

November 7, 2025 By Sean Whooley

The annual Medtronic (NYSE:MDT) diabetes awareness initiative this year has the backing of sporting legend Billie Jean King. King, a former world No. 1 tennis player and pioneer in women's sports, is participating in the company's Blue Balloon … [Read More...] about Billie Jean King supports Medtronic Diabetes awareness initiative

Tandem Diabetes Care updated logo

Tandem stock rises after hours on Q3 beats, record sales

November 6, 2025 By Sean Whooley

Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost after hours today on third-quarter results that came in ahead of the consensus forecast. Shares of TNDM rose nearly 20% to $15.89 apiece in post-market trading today. The San Diego-based … [Read More...] about Tandem stock rises after hours on Q3 beats, record sales

Insulet Omnipod 5 worn on the back of an arm

Insulet leadership talks patch pump competition, expanding type 2 diabetes market

November 6, 2025 By Sean Whooley

As Insulet (Nasdaq:PODD) continues to grow in its leadership position within the insulin patch pump market, other entries could be on the way. The Acton, Massachusetts–based company's Omnipod platform has long been the leader in the patch pump … [Read More...] about Insulet leadership talks patch pump competition, expanding type 2 diabetes market

Insulet logo

Insulet increases guidance again on Q3 beats, 30% sales uptick

November 6, 2025 By Sean Whooley

Insulet (Nasdaq:PODD) shares rose slightly before hours today on third-quarter results that landed well ahead of the consensus forecast. Shares of PODD ticked up 2.4% to $322 apiece in pre-market trading today. The Acton, Massachusetts-based … [Read More...] about Insulet increases guidance again on Q3 beats, 30% sales uptick

Senseonics logo

Senseonics posts Q3 sales beat, expects CE mark for Eversense 365 this year

November 5, 2025 By Sean Whooley

Senseonics (NYSE:SENS) shares ticked up after hours today on third-quarter results that beat the consensus sales forecast. Shares of SENS rose 2.1% to $6.87 apiece in post-market trading today. The Germantown, Maryland-based long-term implantable … [Read More...] about Senseonics posts Q3 sales beat, expects CE mark for Eversense 365 this year

MIT Drug Delivery Patch for heart attack tissue (1)

MIT engineers develop drug delivery patch for post-heart attack healing

November 5, 2025 By Sean Whooley

Engineers at MIT say they developed a flexible drug delivery patch for promoting healing and tissue regeneration after heart attacks. The patch, placed on the heart after a heart attack, can help both heal and regenerate cardiac tissue. MIT said … [Read More...] about MIT engineers develop drug delivery patch for post-heart attack healing

Tandem Diabetes Care ISO IEC Certified

Tandem achieves cybersecurity certification milestone

November 4, 2025 By Sean Whooley

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it achieved ISO/IEC 27001:2022 Certification from Insight Assurance. San Diego-based Tandem said the certification affirms its commitment to cybersecurity, data protection and operational … [Read More...] about Tandem achieves cybersecurity certification milestone

Abbott-Freestyle

12 things you need to know about the CGM market

November 4, 2025 By Chrystal Larsen

The CGM market is an exciting, fast-growing, multibillion-dollar sector for the medical device industry, according to our latest Medtech Market Intelligence Report for MassDevice. The report on the CGM market — available for purchase on MassDevice … [Read More...] about 12 things you need to know about the CGM market

Dexcom Tidepool Oura Metabolic 1 (1)

Tidepool, Oura partner on data for diabetes research

November 4, 2025 By Sean Whooley

Tidepool today announced a strategic collaboration with Oura to support a groundbreaking dataset for diabetes research. The initiative between the diabetes software developer and smart ring maker aims to create a comprehensive, multi-modal, … [Read More...] about Tidepool, Oura partner on data for diabetes research

Dexcom G7 iPhone (1)

Dexcom leadership addresses G7 issue claims, hopes for expanded CGM coverage

October 31, 2025 By Sean Whooley

Amid some scrutiny over its latest-generation G7 continuous glucose monitor (CGM), Dexcom (Nasdaq:DXCM) officials addressed claims on the company's latest earnings call. A recent class action lawsuit brought G7 into the spotlight, demanding a jury … [Read More...] about Dexcom leadership addresses G7 issue claims, hopes for expanded CGM coverage

In case you missed it

  • Modular Medical is seeking CE mark for its next-gen insulin pump
  • CGM market report: Significant growth is ahead
  • Dexcom stock is down after hours despite Q3 beats, raised sales guidance
  • Insulet launches inclusion campaign for Diabetes Awareness Month
  • Tidepool announces new permanent CEO appointment
  • Tandem launches t:slim X2 pump with Abbott FreeStyle Libre 3 Plus
  • Beta Bionics stock rises on Q3 beats, raised full-year guidance, advances iLet offerings
  • Glucose monitor maker LifeScan is set to emerge from Ch. 11 bankruptcy
  • Orchestra BioMed, Terumo terminate drug-eluting balloon distro deal in $30M agreement
  • ViCentra adds Dexcom, Medtronic Diabetes veterans to leadership team
  • Dexcom adds Stanford Medicine chair to its board of directors
  • Boston Scientific shares positive Agent drug-coated balloon findings
  • Vivani prices $15.7M offering
  • Multiple studies back Cordis Selution SLR drug-eluting balloon
  • Ypsomed launches YpsoLoop autoinjector platform designed for circularity

Clinical Trials

Dexcom Tidepool Oura Metabolic 1 (1)

Tidepool, Oura partner on data for diabetes research

Tidepool today announced a strategic collaboration with Oura to support a groundbreaking dataset for diabetes research. The initiative between the diabetes software developer and smart ring maker aims to create a comprehensive, multi-modal, real-world dataset for diabetes, utilizing Tidepool’s diabetes device data paired with biometric data collected by the leading Oura Ring Gen 3. This […]

Boston Scientific Agent drug-coated balloon DCB

Boston Scientific shares positive Agent drug-coated balloon findings

Boston Scientific (NYSE: BSX) today shared findings from new analyses of its Agent drug-coated balloon (DCB). Agent serves as an alternative to traditional therapies like balloon angioplasty, additional layers of stenting or radiation. The paclitaxel-coated balloon transfers a therapeutic dose of drug to the vessel wall, helping to prevent in-stent restenosis (ISR) reoccurrence. The FDA […]

Orchestra BioMed Virtue sirolimus angioinfusion balloon (SAB)

Orchestra BioMed enrolls first patient in Sirolumus AngioInfusion balloon trial

Orchestra BioMed (Nasdaq:OBIO) today announced the first patient enrollments in a study of its Virtue Sirolimus AngioInfusion Balloon (SAB). The FDA investigational device exemption (IDE) trial compares the Virtue SAB to the Boston Scientific Agent paclitaxel-coated balloon. Agent is currently the only FDA-approved drug-coated balloon (DCB) for coronary indication, picking up approval in March. New Hope, […]

Cordis Selution SLR drug-eluting balloon

Multiple studies back Cordis Selution SLR drug-eluting balloon

Cordis today announced new findings from a duo of studies supporting the use of its Selution SLR drug-eluting balloon (DEB) system. Miami Lakes, Florida-based Cordis announced results from the SELUTION DeNovo and SELUTION 4ISR trials at the 2025 Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco. Both randomized clinical trials demonstrated positive outcomes that met […]

SiBionics GS3 CGM (1)

SiBionics reports strong CGM, ketone monitoring data

SiBionics announced the presentation of new data supporting its continuous glucose monitoring (CGM) and ketone monitoring (CKM) devices. The China-based company shared findings for its integrated CGM and CKM diabetes management solution as well. It showcased the technology at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria. […]

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS